Abilify (aripiprazole) Tablets, Orally Disintegrating Tablets, Oral Solution, and Injection for INTRAMUSCULAR USE ONLY

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)   January 2016 ADVERSE REACTIONS Postmarketing Experience addition of pathological gambling and hiccups ...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts